ChartMill assigns a Buy % Consensus number of 83% to VYNT. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-02-03 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-05-17 | HC Wainwright & Co. | Maintains | Buy |
| 2022-03-08 | HC Wainwright & Co. | Maintains | Buy |
| 2021-10-06 | HC Wainwright & Co. | Initiate | Buy |
7 analysts have analysed VYNT and the average price target is 5.1 USD. This implies a price increase of 1861.54% is expected in the next year compared to the current price of 0.26.
The consensus rating for VYANT BIO INC (VYNT) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.